Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 41 of 41 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. | Location Greensboro |
| |
Company Aceragen Inc. | Activity: Research and Development | Company Description Aceragen is a clinical-stage biopharmaceutical company developing therapeutics for rare and orphan pulmonary and rheumatic diseases with high unmet medical need. | Location Research Triangle Park |
| |
Company Adroit Pharmaceutical Development LLC | Activity: Contract Research and Testing | Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. | Location Durham |
| |
Company Aer Therapeutics | Activity: Research and Development | Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. | Location Raleigh |
| |
Company Allergy Partners Extract Laboratory | Activity: Production and Manufacturing | Company Description Allergy Partners' Extract Laboratory produces extracts that are used to treat allergic disease, asthma and immunology. | Location Asheville |
| |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Cary |
| |
Company Arcus-Med LLC | Activity: Research and Development | Company Description Arcus-Med is developing software to diagnose pulmonary hypertension (PH). | Location Raleigh |
| |
Company Areteia Therapeutics Inc. | Activity: Research and Development | Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. | Location Chapel Hill |
| |
Company AstraZeneca (Durham) | Activity: Research and Development | Company Description AstraZeneca's site in Durham develops combination therapies and formulations of inhaled drugs for chronic respiratory diseases such as asthma and COPD. | Location Durham |
| |
Company Aurobindo Pharma USA Inc. | Activity: Research and Development | Company Description Aurobindo Pharma is a generic drug manufacturer. Aurobindo develops inhalation and dermatological products from the company's U.S. research and development headquarters in North Carolina. | Location Durham |
| |
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD Technologies and Innovation develops technologies for parenteral drug delivery, advanced diagnostics, smart medical devices and genomic research and supports external innovation. The RTP site is BD's corporate technology R&D and innovation center. | Location Research Triangle Park |
| |
Company BioMarck Pharmaceuticals Ltd. | Activity: Research and Development | Company Description BioMarck develops drugs to treat pulmonary diseases and disorders, such as chronic obstructive pulmonary disease, ARDS, cystic fibrosis and lung cancer. | Location Durham |
| |
Company BioMedInnovations LLC | Activity: Research and Development | Company Description BioMedInnovations (BMI) develops products for ex vivo perfusion and preservation of organs and tissue. | Location Denver |
| |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary |
| |
Company Circassia Inc. | Activity: Sales and Operations | Company Description Circassia is a diagnostics and management company focused on improving asthma diagnosis and management. | Location Morrisville |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company Columbia Life Systems Inc. | Activity: Research and Development | Company Description Columbia Life Systems is developing a computer-controlled oxygen blender for therapeutic research. | Location Raleigh |
| |
Company Concentrx Pharmaceuticals Inc. | Activity: Research and Development | Company Description Concentrx develops inhaled prescription products for asthma and COPD, including a unit dose disposable dry powder inhaler. | Location Durham |
| |
Company Eldec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. | Location Durham |
| |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park |
| |
Company GSK (RTP) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company GSK (Zebulon) | Activity: Production and Manufacturing | Company Description GlaxoSmithKline manufactures solid-dose products, including tablets and capsules, at its Zebulon facility. The plant also does granulation, drying and packaging, and contract manufacturing of antibiotics for other companies. | Location Zebulon |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Liquidia Corporation | Activity: Research and Development | Company Description Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology. | Location Morrisville |
| |
Company North Carolina Clinical Research | Activity: Contract Research and Testing | Company Description North Carolina Clinical Research conducts phase one through four trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine and bioequivalent studies. | Location Raleigh |
| |
Company Oriel Therapeutics Inc., a Sandoz company (Durham) | Activity: Research and Development | Company Description Oriel operates as Sandoz' product development center, which develops respiratory products as generic alternatives to patented drugs for asthma and COPD. It also develops and commercializes pre-metered unit and multi-dose dry powder delivery systems. | Location Durham |
| |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham |
| |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham |
| |
Company Pneumocyte LLC | Activity: Research and Development | Company Description Pneumocyte develops technologies to diagnose and manage lung injuries. | Location Winston-Salem |
| |
Company Polarean Inc. | Activity: Production and Manufacturing | Company Description Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gas for use in MRI. Investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic response. | Location Durham |
| |
Company Procter & Gamble (Greensboro) | Activity: Production and Manufacturing | Company Description Procter & Gamble manufactures Vicks and other over-the-counter products. | Location Greensboro |
| |
Company PulmonIx LLC | Activity: Contract Research and Testing | Company Description PulmonIx conducts pulmonary, asthma and critical care medicine clinical trials. PulmonIx @ LeBauer Cone Health is a national care center of the Pulmonary Fibrosis Foundation. | Location Greensboro |
| |
Company Recipharm Laboratories Inc. | Activity: Contract Research and Testing | Company Description Recipharm provides product development and manufacturing services covering inhalation products, oral solids, steriles, semi-solids and API, as well as analytical services for pharmaceuticals. | Location Morrisville |
| |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is developing therapies for chronic inflammatory lung diseases including lung transplant, cystic fibrosis (CF), bronchiectasis and COPD. | Location Chapel Hill |
| |
Company RTI International | Activity: Contract Research and Testing | Company Description RTI, an independent, nonprofit institute, offers scientific and technical expertise in social and laboratory sciences, engineering and international development to government and commercial clients worldwide. | Location Research Triangle Park |
| |
Company Spirovation Inc. | Activity: Contract Research and Testing | Company Description Spirovation is a specialty CRO with a focus on the development of breakthrough drugs in respiratory medicine. Spirovation is non-profit, UNC-affiliated entity. | Location Chapel Hill |
| |
Company Sunday Therapeutics Inc. | Activity: Research and Development | Company Description Sunday Therapeutics is developing a humanized monoclonal antibody to prevent chronic lung disease. | Location Durham |
| |
Company United Therapeutics Corp. | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park |
| |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham |
| |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh |